Whilst BRG1 has classically been seen as a tumour suppressor gene, with its loss promoting tumourigenesis in vivo, it has been shown that BRG1 can act in oncogenic roles in some cancers [20,21,22,23,24]. The gene discussed is SMARCA4; the disease is neoplasm.